Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

glasdegib maleate

(glas-DEH-gib MAY-lee-AYT)
A drug used with low-dose cytarabine to treat acute myeloid leukemia that is newly diagnosed. It is used in patients who are 75 years and older or in patients who cannot be treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Glasdegib maleate blocks a type of protein involved in cell growth and repair and may block the growth of cancer cells. It is a type of hedgehog signaling pathway antagonist. Also called Daurismo.
Search NCI's Dictionary of Cancer Terms